Impact of supplementing Limosilactobacillus fermentum MN–LF23 on the eradication of Helicobacter pylori with 14–day standard quadruple therapy: a randomized, double–blind, placebo–controlled trial

Impact of supplementing Limosilactobacillus fermentum MN–LF23 on the eradication of Helicobacter pylori with 14–day standard quadruple therapy: a randomized, double–blind, placebo–controlled trial

Abstract Background The effect of probiotics on Helicobacter pylori (Hp) infection demonstrates considerable heterogeneity. This study aims to elucidate the role of Limosilactobacillus fermentum MN–LF23 (MN–LF23) in Hp–infected populations. Methods A total of 94 adult patients with confirmed Hp infe...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuyang Zhao, Xiaokang Niu, Yong Zhang, Liang Zhao, Liwei Zhang, Jingjing He, Qi Zhang, Yuejian Mao, Fuqing Wang, Xiaohui Zhao, Ran Wang
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Nutrition Journal
Subjects:
Helicobacter pylori
Limosilactobacillus fermentum
Standard quadruple therapy
Gut microbiota
Metagenomic sequencing
Online Access:https://doi.org/10.1186/s12937-025-01124-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items